Who We Are
In a healthcare landscape defined by rapidly shifting regulations, evolving payer expectations, and an ever-growing demand for evidence-based value, getting an innovative therapy or medical product to the patients who need it most is rarely straightforward. That is precisely where we come in.
We are a leading market access consulting company dedicated to helping pharmaceutical, biotechnology, and medical device organisations navigate the complex journey from regulatory approval to real-world patient access. With a team of seasoned healthcare market access consultants, we bridge the gap between clinical innovation and commercial success — ensuring that groundbreaking treatments do not just exist, but are accessible, affordable, and adopted across healthcare systems worldwide.
Our Story
Founded by a group of specialists with deep roots in health economics, reimbursement strategy, and global payer engagement, our firm was built on a single conviction: that exceptional science deserves an equally exceptional path to market. We have witnessed firsthand how even the most transformative therapies can stall at the gates of payer approval, HTA submission, or pricing negotiation, not because they lack value, but because that value has not been communicated effectively.
We set out to change that. Over the years, we have grown into a full-service market access consulting partner trusted by emerging biotech start-ups, mid-sized specialty pharma companies, and global life sciences leaders alike. Our reputation rests on delivering strategies that are not only analytically robust but commercially pragmatic, grounded in the realities of today's healthcare environment.
What We Do
Our market access consulting services cover the full product lifecycle, from early-stage pipeline planning through to post-launch evidence generation. We work collaboratively with your internal teams to design and execute strategies that maximise patient reach while protecting commercial sustainability.
Payer Strategy & Engagement:
We develop evidence-backed value propositions and lead payer engagement programmes that build trust and drive favourable reimbursement outcomes with national and regional healthcare authorities.
Health Technology Assessment (HTA) Support:
Our healthcare market access consultants guide clients through HTA submissions across multiple jurisdictions, including the requirements of the EU HTA Regulation, NICE, G-BA, and beyond — ensuring submissions are compelling, compliant, and strategically positioned.
Pricing & Reimbursement Strategy:
We craft pricing models that balance profitability with payer acceptability, drawing on rigorous market analysis, competitor benchmarking, and health economic modelling to define optimal price points.
Health Economics & Outcomes Research:
From cost-effectiveness analyses to budget impact models and patient-reported outcomes assessment, our HEOR team generates the evidence base that underpins every access decision.
Value Communication & Dossier Development:
We translate complex clinical and economic data into clear, persuasive narratives that resonate with decision-makers — whether they are payers, HTA bodies, hospital formulary committees, or healthcare providers.
Real-World Evidence (RWE) Strategy :
We design post-launch real-world evidence programmes that sustain access, support label expansions, and address evolving payer requirements across your product’s commercial life.
While we have strong expertise in Switzerland, we also support broader European market access strategies.
You can contact us to schedule an initial consultation. We will discuss your objectives, timelines, and challenges before defining a tailored engagement plan.
Why Choose Us?
With over 20 years of international experience in market access consulting, we bring a rare combination of local expertise and a trusted global network. Our team of senior healthcare market access consultants, with backgrounds at Novartis, Pfizer, AstraZeneca, and leading HTA bodies, goes beyond strategy to deliver real results. As a dedicated market access consulting company, we combine scientific rigour, payer insight, and hands-on negotiation support to get your product to patients.
Our Commitment
At the heart of everything we do is a commitment to patients. Regulatory approval is only the beginning of a product's journey. Without a strong, well-executed market access strategy, even the most innovative therapies risk remaining out of reach for the people who need them. Our role as healthcare market access consultants is to ensure that never happens.
We are committed to helping your organization demonstrate value, secure access, and ultimately deliver better health outcomes, at scale, across markets, and across every stage of your product's lifecycle.
Let's bring your innovation to the patients who need it most. Let's talk.
Schedule A Call.
Why Choose Us?
Trusted by 500+ satisfied customers with over 10+ years of experience in global healthcare markets.
Get in Touch
Fill out the form below and our team will get back to you shortly.